A Review of Nonhuman Primate Models of Rift Valley Fever Virus Infection: Progress, Challenge Strains, and Future Directions

被引:0
作者
Ebisine, Kimimuepigha [1 ]
Quist, Darcy [1 ]
Findlay-Wilson, Stephen [1 ]
Kennedy, Emma [1 ]
Dowall, Stuart [1 ]
机构
[1] UK Hlth Secur Agcy, Salisbury SP4 0JG, England
来源
PATHOGENS | 2024年 / 13卷 / 10期
关键词
rift valley fever; nonhuman primate; vaccine; model; RHESUS MACAQUES; LABORATORY INFECTION; SEROLOGICAL EVIDENCE; SAUDI-ARABIA; HUMANS; MONKEYS; DISEASE; EGYPT; VIRULENCE; EPIDEMIC;
D O I
10.3390/pathogens13100856
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Rift Valley fever (RVF) is a mosquito-borne viral disease that primarily affects animals, especially ruminants, but has the capacity to infect humans and result in outbreaks. Infection with the causative agent, RVF virus (RVFV), causes severe disease in domestic animals, especially sheep, resulting in fever, anorexia, immobility, abortion, and high morbidity and mortality rates in neonate animals. Humans become infected through exposure to infected animals and, less frequently, directly via a mosquito bite. A greater awareness of RVFV and its epidemic potential has resulted in increased investment in the development of interventions, especially vaccines. There is currently no substitute for the use of animal models in order to evaluate these vaccines. As outbreaks of RVF disease are difficult to predict or model, conducting Phase III clinical trials will likely not be feasible. Therefore, representative animal model systems are essential for establishing efficacy data to support licensure. Nonhuman primate (NHP) species are often chosen due to their closeness to humans, reflecting similar susceptibility and disease kinetics. This review covers the use of NHP models in RVFV research, with much of the work having been conducted in rhesus macaques and common marmosets. The future direction of RVF work conducted in NHP is discussed in anticipation of the importance of it being a key element in the development and approval of a human vaccine.
引用
收藏
页数:16
相关论文
共 104 条
  • [1] An epizootic of Rift Valley fever in Egypt in 1997
    Abd El-Rahim, IHA
    Abd El-Hakim, U
    Hussein, M
    [J]. REVUE SCIENTIFIQUE ET TECHNIQUE DE L OFFICE INTERNATIONAL DES EPIZOOTIES, 1999, 18 (03): : 741 - 748
  • [2] The Status of Rift Valley Fever in Animals in Saudi Arabia: A Mini Review
    Al-Afaleq, Adel I.
    Hussein, Mansour F.
    [J]. VECTOR-BORNE AND ZOONOTIC DISEASES, 2011, 11 (12) : 1513 - 1520
  • [3] Serological Evidence of Antibodies to Rift Valley Fever Virus in Wild and Domestic Animals in Bauchi State, Nigeria
    Atuman, Y. J.
    Kudi, C. A.
    Abdu, P. A.
    Okubanjo, O. O.
    Wungak, Y.
    Ularamu, H. G.
    Abubakar, A.
    [J]. VETERINARY MEDICINE INTERNATIONAL, 2022, 2022
  • [4] Seroprevalence and Risk Factors Associated with Phleboviruses and Crimean-Congo Hemorrhagic Fever Virus among Blood Donors in Central Tunisia
    Ayari, Rym
    Chaouch, Houda
    Findlay-Wilson, Stephen
    Hachfi, Wissem
    Lasfar, Nadia Ben
    Bellazreg, Foued
    Dowall, Stuart
    Hannachi, Neila
    Letaief, Amel
    [J]. PATHOGENS, 2024, 13 (04):
  • [5] Choice of inbred rat strain impacts lethality and disease course after respiratory infection with Rift Valley Fever Virus
    Bales, Jacquelyn M.
    Powell, Diana S.
    Bethel, Laura M.
    Reed, Douglas S.
    Hartman, Amy L.
    [J]. FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2012, 2 : 105
  • [6] Rift Valley Fever Virus Infection Causes Acute Encephalitis in the Ferret
    Barbeau, Dominique J.
    Albe, Joseph R.
    Nambulli, Sham
    Tilston-Lunel, Natasha L.
    Hartman, Amy L.
    Lakdawala, Seema S.
    Klein, Ed
    Duprex, W. Paul
    McElroy, Anita K.
    [J]. MSPHERE, 2020, 5 (05)
  • [7] Bian T, 2023, NPJ VACCINES, V8, DOI [10.1038/s41541-023-00780-1, 10.1038/s41541-023-00763-2]
  • [8] Rift Valley fever virus lacking NSm proteins retains high virulence in vivo and may provide a model of human delayed onset neurologic disease
    Bird, Brian H.
    Albarino, Cesar G.
    Nichol, Stuart T.
    [J]. VIROLOGY, 2007, 362 (01) : 10 - 15
  • [9] The Change P82L in the Rift Valley Fever Virus NSs Protein Confers Attenuation in Mice
    Borrego, Belen
    Moreno, Sandra
    de la Losa, Nuria
    Weber, Friedemann
    Brun, Alejandro
    [J]. VIRUSES-BASEL, 2021, 13 (04):
  • [10] A Hyper-Attenuated Variant of Rift Valley Fever Virus Generated by a Mutagenic Drug (Favipiravir) Unveils Potential Virulence Markers
    Borrego, Belen
    Brun, Alejandro
    [J]. FRONTIERS IN MICROBIOLOGY, 2021, 11